[Seminar] Ministry of Health, Labour and Welfare: Overview of the Act on Securing Safety for Regenerative Medicine and Recent Trends
Based on the latest trends, a detailed explanation of the key points of the system and practical considerations.
Our company will hold a business seminar. 【Seminar Details】 ■ Date and Time: May 21, 2026 (Thursday) 09:30 - 11:30 (Doors open at 9:00) ■ Venue: JPI Conference Square ■ Address: 5-2-32 Minamiazabu, Minato-ku, Tokyo, Kowa Hiroo Building ■ Participation Method: In-person, live streaming, archived streaming ■ Instructor: Ministry of Health, Labour and Welfare Health Policy Bureau, Research and Development Policy Division, Regenerative Medicine Research Promotion Office Assistant Director Takahiko Nagai *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
**Lecture Overview** The "Act on Securing Safety for Regenerative Medicine, etc." (hereinafter referred to as "this Act") was enacted in 2013 with the aim of promoting the rapid and safe provision and dissemination of regenerative medicine, and has been in effect since the following year. This Act stipulates the matters that medical institutions must comply with when providing regenerative medicine, as well as the systems related to the manufacturing of specific cell processing products used in regenerative medicine. In Japan, clinical research involving regenerative medicine, cell therapy, and gene therapy falls under the scope of this Act. This lecture will explain the outline of this Act, the amendments to the law, and recent trends related to this Act. **Lecture Items** ■ Overview of the Act on Securing Safety for Regenerative Medicine ■ Medical technologies subject to the Act on Securing Safety for Regenerative Medicine and risk classification ■ Standards for providing regenerative medicine and matters related to the provision plan ■ Matters concerning the Certified Regenerative Medicine Committee ■ Matters concerning facilities for manufacturing specific cell processing products ■ Provisions of the supplementary provisions of the amended law ■ Information on procedures based on the Act on Securing Safety for Regenerative Medicine ■ Related Q&A ■ Business card and information exchange meeting
Price information
[Course Fee] 1 person: 37,430 yen (including tax) Special offer: One additional person from the same organization can attend for free (registration required) *For those affiliated with local public organizations, up to two people can attend for 11,000 yen (including tax / venue and live streaming only / same course format)
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
JPI Corporation (Japan Planning Institute) has been providing valuable information for executives and senior management involved in the execution of national policies and national projects, supporting the dissemination of state policies as a 'bridge of knowledge' between 'government', 'administration', and 'citizens' in the form of exclusive real seminars for participants for half a century, aiming to create national knowledge.
